Overview

To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
Study to assess the effect of Rifampicin on the pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Rifampin